Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 91

1.

Cutting back on pro-protein convertases: the latest approaches to pharmacological inhibition.

Fugère M, Day R.

Trends Pharmacol Sci. 2005 Jun;26(6):294-301. Review.

PMID:
15925704
[PubMed - indexed for MEDLINE]
2.

Inhibitors of proprotein convertases.

Basak A.

J Mol Med (Berl). 2005 Nov;83(11):844-55. Epub 2005 Oct 8. Review.

PMID:
16215768
[PubMed - indexed for MEDLINE]
3.

[Structure and properties of proprotein convertase inhibitors].

Kibirev VK, Osadchuk TV.

Ukr Biokhim Zh. 2012 Mar-Apr;84(2):5-29. Review. Russian.

PMID:
22642118
[PubMed - indexed for MEDLINE]
4.

Potential opportunity in the development of new therapeutic agents based on endogenous and exogenous inhibitors of the proprotein convertases.

Bontemps Y, Scamuffa N, Calvo F, Khatib AM.

Med Res Rev. 2007 Sep;27(5):631-48. Review.

PMID:
17019676
[PubMed - indexed for MEDLINE]
5.

Novel circular, cyclic and acyclic Ψ(CH(2)O) containing peptide inhibitors of SKI-1/S1P: synthesis, kinetic and biochemical evaluations.

Majumdar S, Chen A, Palmer-Smith H, Basak A.

Curr Med Chem. 2011;18(18):2770-82.

PMID:
21568902
[PubMed - indexed for MEDLINE]
6.

Substrate cleavage analysis of furin and related proprotein convertases. A comparative study.

Remacle AG, Shiryaev SA, Oh ES, Cieplak P, Srinivasan A, Wei G, Liddington RC, Ratnikov BI, Parent A, Desjardins R, Day R, Smith JW, Lebl M, Strongin AY.

J Biol Chem. 2008 Jul 25;283(30):20897-906. doi: 10.1074/jbc.M803762200. Epub 2008 May 27.

PMID:
18505722
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

The proprotein convertases are potential targets in the treatment of dyslipidemia.

Seidah NG, Prat A.

J Mol Med (Berl). 2007 Jul;85(7):685-96. Epub 2007 Mar 10. Review.

PMID:
17351764
[PubMed - indexed for MEDLINE]
8.

Furin-like proprotein convertases are central regulators of the membrane type matrix metalloproteinase-pro-matrix metalloproteinase-2 proteolytic cascade in atherosclerosis.

Stawowy P, Meyborg H, Stibenz D, Borges Pereira Stawowy N, Roser M, Thanabalasingam U, Veinot JP, Chrétien M, Seidah NG, Fleck E, Graf K.

Circulation. 2005 May 31;111(21):2820-7. Epub 2005 May 23.

PMID:
15911696
[PubMed - indexed for MEDLINE]
Free Article
9.

The potential anti-tumorigenic and anti-metastatic side of the proprotein convertases inhibitors.

Lahlil R, Calvo F, Khatib AM.

Recent Pat Anticancer Drug Discov. 2009 Jan;4(1):83-91. Review.

PMID:
19149690
[PubMed - indexed for MEDLINE]
10.

The proprotein convertase SKI-1/S1P. In vitro analysis of Lassa virus glycoprotein-derived substrates and ex vivo validation of irreversible peptide inhibitors.

Pasquato A, Pullikotil P, Asselin MC, Vacatello M, Paolillo L, Ghezzo F, Basso F, Di Bello C, Dettin M, Seidah NG.

J Biol Chem. 2006 Aug 18;281(33):23471-81. Epub 2006 Jun 21.

PMID:
16790437
[PubMed - indexed for MEDLINE]
Free Article
11.

Inhibitors of the subtilase-like pro-protein convertases (SPCs).

Fugère M, Day R.

Curr Pharm Des. 2002;8(7):549-62. Review.

PMID:
11945158
[PubMed - indexed for MEDLINE]
12.

Proprotein convertases: lessons from knockouts.

Scamuffa N, Calvo F, Chrétien M, Seidah NG, Khatib AM.

FASEB J. 2006 Oct;20(12):1954-63. Review.

PMID:
17012247
[PubMed - indexed for MEDLINE]
Free Article
13.

Precursor convertases in the secretory pathway, cytosol and extracellular milieu.

Seidah NG, Prat A.

Essays Biochem. 2002;38:79-94. Review.

PMID:
12463163
[PubMed - indexed for MEDLINE]
14.

The proprotein convertases, 20 years later.

Seidah NG.

Methods Mol Biol. 2011;768:23-57. doi: 10.1007/978-1-61779-204-5_3. Review.

PMID:
21805237
[PubMed - indexed for MEDLINE]
15.

Proprotein convertases as therapeutic targets.

Chrétien M, Seidah NG, Basak A, Mbikay M.

Expert Opin Ther Targets. 2008 Oct;12(10):1289-300. doi: 10.1517/14728222.12.10.1289 .

PMID:
18781827
[PubMed - indexed for MEDLINE]
16.

Processing of peptide and hormone precursors at the dibasic cleavage sites.

Rholam M, Fahy C.

Cell Mol Life Sci. 2009 Jul;66(13):2075-91. doi: 10.1007/s00018-009-0007-5. Epub 2009 Mar 20. Review.

PMID:
19300906
[PubMed - indexed for MEDLINE]
17.

The biology and therapeutic targeting of the proprotein convertases.

Seidah NG, Prat A.

Nat Rev Drug Discov. 2012 May;11(5):367-83. Review.

PMID:
22679642
[PubMed - indexed for MEDLINE]
18.

Proprotein convertases furin and PC5: targeting atherosclerosis and restenosis at multiple levels.

Stawowy P, Fleck E.

J Mol Med (Berl). 2005 Nov;83(11):865-75. Epub 2005 Oct 22. Review.

PMID:
16244876
[PubMed - indexed for MEDLINE]
19.

Proprotein convertase inhibitory activities of flavonoids isolated from Oroxylum indicum.

Majumdar S, Mohanta BC, Chowdhury DR, Banik R, Dinda B, Basak A.

Curr Med Chem. 2010;17(19):2049-58.

PMID:
20423311
[PubMed - indexed for MEDLINE]
20.

Role of subtilisin-like convertases in cadherin processing or the conundrum to stall cadherin function by convertase inhibitors in cancer therapy.

Müller EJ, Caldelari R, Posthaus H.

J Mol Histol. 2004 Mar;35(3):263-75. Review.

PMID:
15339046
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk